Cargando…
Where Can Patients Obtain Information on the Preapproval Access Pathway to Investigational Treatment in Japan? A Survey of Patient Advocacy Organizations’ Websites
Investigational treatments are those that have been approved for testing in humans but are not yet available as an approved treatment option. For many patients with a terminal illness who have no approved treatment option and are not eligible for a clinical trial, investigational treatments are the...
Autores principales: | Nakada, Haruka, Takashima, Kyoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916578/ https://www.ncbi.nlm.nih.gov/pubmed/31592580 http://dx.doi.org/10.1002/cpdd.745 |
Ejemplares similares
-
Best practices in designing preapproval information engagements for US health care decision makers
por: Dodda, Sai, et al.
Publicado: (2023) -
Patient advocacy and DSM-5
por: Stein, Dan J, et al.
Publicado: (2013) -
Research priorities to support evidence-informed policies and advocacy for access to safe abortion care in sub-Saharan Africa
por: Ajayi, Anthony Idowu, et al.
Publicado: (2021) -
(R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments
por: Hogan, Melissa
Publicado: (2016) -
International dermatology: Patient care, research, and advocacy
por: Kantor, Jonathan
Publicado: (2020)